Changes to the Code
H.R. 8377 · Stop Deadly Denials Act of 2026 · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 1315a Center for Medicare and Medicaid Innovation
3 changes the bill asks for here, 3 carried out
- Carried out:
in subparagraph (A), by striking
The Secretary shall select
and insertingSubject to the limitation under subparagraph (D), the Secretary shall select
; and - Carried out:
by adding at the end the following new subparagraph:
(D) Limitation on models to be tested.— Beginning on the date of the enactment of this subparagraph, the Secretary may not select a model to be tested under subparagraph (A) if such model— (i) would provide for the implementation of prior authorization with respect to items or …
- Carried out:
Section 1115A(b)(2)(A) of the Social Security Act (42 U.S.C. 1315a(b)(2)(A)), as amended by subsection (b), is further amended by adding at the end the following new sentence:
Beginning January 1, 2027, a model may only be selected under this subparagraph after notice and opportunity for public comment.
.
§ 1315a(b)Testing of models (phase I)(1)–(2)
Start of § 1315a to (b) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (1) | (1) In general | (1) In general | ||
| The CMI shall test payment and service delivery models in accordance with selection criteria under paragraph (2) to determine the effect of applying such models under the applicable subchapter (as defined in subsection (a)(4)(B)) on program expenditures under such subchapters and the quality of care received by individuals receiving benefits under such subchapter. | The CMI shall test payment and service delivery models in accordance with selection criteria under paragraph (2) to determine the effect of applying such models under the applicable subchapter (as defined in subsection (a)(4)(B)) on program expenditures under such subchapters and the quality of care received by individuals receiving benefits under such subchapter. | |||
| (2) | (2) Selection of models to be tested | (2) Selection of models to be tested | ||
| (2)(A) | (A) In general | (A) In general | ||
| [inserted: Subject] [inserted: to the limitation under subparagraph (D), the ]Secretary shall select models to be tested from models where the Secretary determines that there is evidence that the model addresses a defined population for which there are deficits in care leading to poor clinical outcomes or potentially avoidable expenditures. The Secretary shall focus on models expected to reduce program costs under the applicable subchapter while preserving or enhancing the quality of care received by individuals receiving benefits under such subchapter. The models selected under this subparagraph may include, but are not limited to, the models described in subparagraph (B).[inserted: Beginning January 1, 2027, a model may only be selected under this subparagraph after notice and opportunity for public comment.] | ||||
| (2)(B) | (B) Opportunities | (B) Opportunities | ||
| The models described in this subparagraph are the following models: | The models described in this subparagraph are the following models: | |||
| (2)(B)(i) | (i) | (i) | ||
| Promoting broad payment and practice reform in primary care, including patient-centered medical home models for high-need applicable individuals, medical homes that address women’s unique health care needs, and models that transition primary care practices away from fee-for-service based reimbursement and toward comprehensive payment or salary-based payment. | Promoting broad payment and practice reform in primary care, including patient-centered medical home models for high-need applicable individuals, medical homes that address women’s unique health care needs, and models that transition primary care practices away from fee-for-service based reimbursement and toward comprehensive payment or salary-based payment. |
§ 1315a(b)Testing of models (phase I)(2)–(3)
(b)(2)(B)(ii)–(C)(vi) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (2)(C)(vii) | (vii) | (vii) | ||
| Whether, under the model, providers of services and suppliers are able to share information with patients, caregivers, and other providers of services and suppliers on a real time basis. | Whether, under the model, providers of services and suppliers are able to share information with patients, caregivers, and other providers of services and suppliers on a real time basis. | |||
| (2)(C)(viii) | (viii) | (viii) | ||
| Whether the model demonstrates effective linkage with other public sector payers, private sector payers, or statewide payment models. | Whether the model demonstrates effective linkage with other public sector payers, private sector payers, or statewide payment models. | |||
| (2)(D) | (D) [inserted: Limitation on models to be tested.—] | |||
| [inserted: Beginning on the date of the enactment of this subparagraph, the Secretary may not select a model to be tested under subparagraph (A) if such model—] | ||||
| (2)(D)(i) | (i) [inserted: ] | |||
| [inserted: would provide for the implementation of prior authorization with respect to items or services for which payment may be made under part A or part B of title XVIII; and] | ||||
| (2)(D)(ii) | (ii) [inserted: ] | |||
| [inserted: would provide for—] | ||||
| (2)(D)(ii)(I) | (I) [inserted: ] | |||
| [inserted: issuing any denial of coverage or payment that—] | ||||
| (2)(D)(ii)(I)(aa) | (aa) [inserted: ] | |||
| [inserted: is based on a decision made through the use of artificial intelligence, machine learning, algorithmic-derived decision logic, or any other similar technological process, without review and approval of such denial; and] | ||||
| (2)(D)(ii)(I)(bb) | (bb) [inserted: ] | |||
| [inserted: has not been individually reviewed and approved by a physician on the basis of the physician’s independent medical judgment, taking into account relevant documentation provided by the individual receiving such items or services or the provider furnishing such items or services; or] | ||||
| (2)(D)(ii)(II) | (II) [inserted: ] | |||
| [inserted: the processing of requests for prior authorization by any entity other than a medicare administrative contractor with a contract under section 1874A.] | ||||
| (3) | (3) Budget neutrality | (3) Budget neutrality | ||
| (3)(A) | (A) Initial period | (A) Initial period | ||
| The Secretary shall not require, as a condition for testing a model under paragraph (1), that the design of such model ensure that such model is budget neutral initially with respect to expenditures under the applicable subchapter. | The Secretary shall not require, as a condition for testing a model under paragraph (1), that the design of such model ensure that such model is budget neutral initially with respect to expenditures under the applicable subchapter. | |||
Rest of § 1315a unchanged
42 U.S.C. § 1395w–22 Benefits and beneficiary protections
3 changes the bill asks for here, 3 carried out
- Carried out:
Section 1852 of the Social Security Act (42 U.S.C. 1395w–22) is amended by adding at the end the following new subsection:
(o) Limitation on prior authorization.— (1) In general.— Subject to paragraph (2), for plan years beginning on or after January 1, 2027, a Medicare Advantage plan may not impose any prior authorization requirement with respect to any specified item or service. (2) Exception.— …
- Carried out:
in the subparagraph heading, by striking
Prior authorization
and insertingReview
; and - Carried out:
by inserting
for plan years ending before January 1, 2027,
afterRules regarding prior authorization
.
§ 1395w–22(c)(1)Detailed description of plan provisions(F)–(I)
Start of § 1395w–22 to (c)(1)(F)(i) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (F)(ii) | (ii) | (ii) | ||
| the supplemental benefits covered, and | the supplemental benefits covered, and | |||
| (F)(iii) | (iii) | (iii) | ||
| the Medicare+Choice monthly supplemental beneficiary premium for the supplemental benefits. | the Medicare+Choice monthly supplemental beneficiary premium for the supplemental benefits. | |||
| (G) | (G) | (G) [inserted: Review] rules | ||
| Rules regarding prior authorization or other review requirements that could result in nonpayment. | Rules regarding prior authorization [inserted: for plan years ending before January 1, 2027, ]or other review requirements that could result in nonpayment. | |||
| (H) | (H) Plan grievance and appeals procedures | (H) Plan grievance and appeals procedures | ||
| All plan appeal or grievance rights and procedures. | All plan appeal or grievance rights and procedures. | |||
| (I) | (I) Quality improvement program | (I) Quality improvement program | ||
| A description of the organization’s quality improvement program under subsection (e). | A description of the organization’s quality improvement program under subsection (e). |
§ 1395w–22(n)–(o)
(c)(2)–(n) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (n)(1) | (1) In general | (1) In general | ||
| In the case of an individual enrolled under an MA or MA–PD plan who is furnished an in-home health risk assessment on or after January 1, 2021, such plan shall ensure that such assessment includes information on the safe disposal of prescription drugs that are controlled substances that meets the criteria established under paragraph (2). Such information shall include information on drug takeback programs that meet such requirements determined appropriate by the Secretary and information on in-home disposal. | In the case of an individual enrolled under an MA or MA–PD plan who is furnished an in-home health risk assessment on or after January 1, 2021, such plan shall ensure that such assessment includes information on the safe disposal of prescription drugs that are controlled substances that meets the criteria established under paragraph (2). Such information shall include information on drug takeback programs that meet such requirements determined appropriate by the Secretary and information on in-home disposal. | |||
| (n)(2) | (2) Criteria | (2) Criteria | ||
| The Secretary shall, through rulemaking, establish criteria the Secretary determines appropriate with respect to information provided to an individual to ensure that such information sufficiently educates such individual on the safe disposal of prescription drugs that are controlled substances. | The Secretary shall, through rulemaking, establish criteria the Secretary determines appropriate with respect to information provided to an individual to ensure that such information sufficiently educates such individual on the safe disposal of prescription drugs that are controlled substances. | |||
| (o) | (o) [inserted: Limitation on prior authorization.—] | |||
| (o)(1) | (1) [inserted: In general.—] | |||
| [inserted: Subject to paragraph (2), for plan years beginning on or after January 1, 2027, a Medicare Advantage plan may not impose any prior authorization requirement with respect to any specified item or service.] | ||||
| (o)(2) | (2) [inserted: Exception.—] | |||
| [inserted: Paragraph (1) shall not apply with respect to a specified item or service for a plan year in the case that, during such year, such item or service is subject to prior authorization pursuant to subsection (t)(2)(F) or (aa) of section 1833, subsection (a)(15), (l)(16), (q)(6), or (u)(4) of section 1834, or any other provision of part A or part B of this title.] | ||||
| (o)(3) | (3) [inserted: Specified item or service defined.—] | |||
| [inserted: For purposes of this subsection, the term “specified item or service” means, with respect to a Medicare Advantage plan, any item or service for which benefits are available under such plan that is not—] | ||||
| (o)(3)(A) | (A) [inserted: ] | |||
| [inserted: a covered part D drug; or] | ||||
| (o)(3)(B) | (B) [inserted: ] | |||
| [inserted: a supplemental health care benefit (as described in subsection (a)(3)).] | ||||
42 U.S.C. § 1395w–27 Contracts with Medicare+Choice organizations
4 changes the bill asks for here, 2 carried out
- Not carried out:
in subparagraph (J), by striking
or
at the end;The bill strikes “or” at the end of § 1395w–27(g)(1)(J), but the text there doesn't end with it. The law may have changed since the bill was drafted.
Technical detail
“or” is not at the end of /us/usc/t42/s1395w–27/g/1/J - Not carried out:
in subparagraph (K), by striking
subparagraphs (A) through (J)
and insertingsubparagraphs (A) through (K)
;“subparagraphs (A) through (J)” isn't in § 1395w–27(g)(1)(K) in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“subparagraphs (A) through (J)” not found in /us/usc/t42/s1395w–27/g/1/K - Carried out:
by redesignating subparagraph (K) as subparagraph (L); and
The section already has a provision under this letter or number, so it would have two.
- Carried out:
by inserting after subparagraph (J) the following new subparagraph:
(K) imposes a prior authorization requirement with respect to an item or service in violation of section 1852(o); or.
This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.
§ 1395w–27(g)(1)In general(I)–(L)
Start of § 1395w–27 to (g)(1)(H) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (I) | (I) | (I) | ||
| transfers an individual enrolled under this part from one plan to another without the prior consent of the individual or the designee of the individual or solely for the purpose of earning a commission; | transfers an individual enrolled under this part from one plan to another without the prior consent of the individual or the designee of the individual or solely for the purpose of earning a commission; | |||
| (J) | (J) | (J) | ||
| fails to comply with marketing restrictions described in subsections (h) and (j) of section 1395w–21 of this title or applicable implementing regulations or guidance; | fails to comply with marketing restrictions described in subsections (h) and (j) of section 1395w–21 of this title or applicable implementing regulations or guidance; | |||
| (K) | (K) [inserted: ] | |||
| [inserted: imposes a prior authorization requirement with respect to an item or service in violation of section 1852(o); or] | ||||
| (L) | [inserted: (L)] | |||
| fails to comply with the standards for reasonable and relevant contract terms and conditions under subparagraph (A)(ii) of section 1395w–104(b)(1) of this title or violates the provisions of subparagraph (F)(i)(VIII) of such section; or | fails to comply with the standards for reasonable and relevant contract terms and conditions under subparagraph (A)(ii) of section 1395w–104(b)(1) of this title or violates the provisions of subparagraph (F)(i)(VIII) of such section; or | |||
| (L) | (L) | (L) | ||
| employs or contracts with any individual or entity who engages in the conduct described in subparagraphs (A) through (K) of this paragraph; | employs or contracts with any individual or entity who engages in the conduct described in subparagraphs (A) through (K) of this paragraph; | |||
| (1) | the Secretary may provide, in addition to any other remedies authorized by law, for any of the remedies described in paragraph (2). The Secretary may provide, in addition to any other remedies authorized by law, for any of the remedies described in paragraph (2), if the Secretary determines that any employee or agent of such organization, or any provider or supplier who contracts with such organization, has engaged in any conduct described in subparagraphs (A) through (L) of this paragraph. | the Secretary may provide, in addition to any other remedies authorized by law, for any of the remedies described in paragraph (2). The Secretary may provide, in addition to any other remedies authorized by law, for any of the remedies described in paragraph (2), if the Secretary determines that any employee or agent of such organization, or any provider or supplier who contracts with such organization, has engaged in any conduct described in subparagraphs (A) through (L) of this paragraph. | ||
Rest of § 1395w–27 unchanged